Bridgewater Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,500
Closed -$35K 239
2022
Q2
$35K Hold
17,500
0.01% 223
2022
Q1
$41K Hold
17,500
0.01% 238
2021
Q4
$81K Sell
17,500
-22,000
-56% -$102K 0.02% 242
2021
Q3
$301K Buy
39,500
+7,000
+22% +$53.3K 0.08% 189
2021
Q2
$315K Buy
+32,500
New +$315K 0.1% 179